Javelin Pharmaceuticals Inc (JAV)

[stuck_holder]

<Shorting a stock under $5 isn't permitted in the U.S.>

fyi, short interest in DNDN increased 60% from jan to mar to approximately 40% of the float while the stock was trading below $5 prior to its advisory committee meeting.

that was a heavily manipulated stock (later appeared on Reg SHO) and is just one example i am rather familiar with - there are are many other biotechs under $5 where short positions exist and have increased while under $5.

in fact, development stage biotechs are a popular short candidate for hedge funds exactly because most of them never manage to get a drug approved.